Balyasny Asset Management
BNTX icon

Balyasny Asset Management’s BioNTech BNTX Stock Holding History

Balyasny Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.31M Buy
93,455
+90,043
+2,639% +$9.25M 0.01% 1118
2025
Q4 		$325K Buy
+3,412
New +$344K ﹤0.01% 2699
2025
Q2 		– Sell
-37,756
Closed -$3.44M – 2848
2025
Q1 		$3.44M Buy
+37,756
New +$4.23M 0.01% 1433
2024
Q4 		– Sell
-620,466
Closed -$73.7M – 2758
2024
Q3 		$73.7M Buy
620,466
+164,548
+36% +$15.1M 0.12% 187
2024
Q2 		$36.6M Buy
455,918
+265,816
+140% +$24.3M 0.06% 385
2024
Q1 		$17.5M Buy
+190,102
New +$18.2M 0.03% 674
2023
Q4 		– Sell
-348,728
Closed -$37.9M – 2509
2023
Q3 		$37.9M Buy
348,728
+195,104
+127% +$21.6M 0.08% 353
2023
Q2 		$16.6M Buy
+153,624
New +$17.3M 0.04% 593
2023
Q1 		– Sell
-113,528
Closed -$17.1M – 2671
2022
Q4 		$17.1M Buy
113,528
+105,691
+1,349% +$16.3M 0.05% 545
2022
Q3 		$1.06M Buy
7,837
+2,864
+58% +$438K ﹤0.01% 1771
2022
Q2 		$741K Sell
4,973
-103,495
-95% -$15.8M ﹤0.01% 1864
2022
Q1 		$18.5M Buy
+108,468
New +$18.2M 0.06% 444
2021
Q4 		– Sell
-38,455
Closed -$10.5M – 2253
2021
Q3 		$10.5M Buy
+38,455
New +$12.2M 0.04% 555
2020
Q4 		– Sell
-181,619
Closed -$17.8M – 1343
2020
Q3 		$12.6M Sell
181,619
-34,166
-16% -$2.45M 0.09% 323
2020
Q2 		$14.4M Buy
+215,785
New +$10.8M 0.12% 248

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Balyasny Asset Management's BNTX Position: Q1 2026 in Review

Balyasny Asset Management increased its BioNTech (BNTX) stake by 2,639% in Q1 2026, buying an estimated $9.25M and bringing the position to 93,455 shares worth $8.31M. The position accounts for 0.01% of the portfolio, ranked #1118.

Balyasny Asset Management first reported a position in BNTX in Q2 2020 and has held it in 15 quarters since. The position peaked at $73.7M in Q3 2024. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Balyasny Asset Management held 93,455 shares of BioNTech worth $8.31M as of Q1 2026.
  • Balyasny Asset Management bought 90,043 BioNTech shares in Q1 2026, an estimated $9.25M.
  • BioNTech made up 0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1118 holding.
  • Balyasny Asset Management first reported a position in BioNTech in Q2 2020 and has held it in 15 quarters since.
  • Balyasny Asset Management's BioNTech position peaked at $73.7M in Q3 2024.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.